Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
Heleen M.A. Hendriksen(MACOM (United States)), Wiesje M. van der Flier(Amsterdam Neuroscience), Leonie N.C. Visser(Utrecht University), Denise Visser(University Medical Center Utrecht), Elsmarieke van de Giessen(Amsterdam Neuroscience), Tanja J. de Rijke(GGD Amsterdam), Jetske van der Schaar(Amsterdam Neuroscience), Agnetha D. Fruijtier(Amsterdam UMC Location University of Amsterdam), Ellen M.A. Smets(Amsterdam University Medical Centers), Calvin Trieu(Amsterdam Neuroscience), Mardou S. S. A. van Leeuwenstijn‐Koopman(Amsterdam Neuroscience), Argonde C. van Harten(Amsterdam Neuroscience)
Cited by 15
Related Papers
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
|Journal of Neurology Neurosurgery & Psychiatry|2010|776